Nexgel (NXGL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $5.59, +7.92% vs the prior close of $5.18.
- Volume 53.62K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NXGL jumps 7.9% to $5.59, a 1-month high. Closed at $5.59, +7.92% vs the prior close of $5.18. Day range $5.10–$5.87, opened at $5.10.
NXGL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NXGL jumps 7.9% to $5.59, a 1-month high
- Closed at $5.59, +7.92% vs the prior close of $5.18. Day range $5.10–$5.87, opened at $5.10.
- Volume was 53.62K shares, 0.4x its 50-day average of 133.34K — lighter than usual.
- Price is -5.2% vs its 50-day average ($5.90) and -60.1% vs its 200-day average ($14.01).
- 52-week range $3.00–$57.00; today's close sits at 5% of that range, 90.2% below the 52-week high.
Oct 15, 2026 — NXGL slides 5.1% to $5.18
- Closed at $5.18, -5.13% vs the prior close of $5.46. Day range $4.06–$5.53, opened at $4.91.
- Volume was 164.60K shares, 1.3x its 50-day average of 130.11K.
- Price is -12.5% vs its 50-day average ($5.92) and -63.4% vs its 200-day average ($14.14).
- 52-week range $3.00–$57.00; today's close sits at 4% of that range, 90.9% below the 52-week high.
Oct 14, 2026 — NXGL jumps 34.8% to $5.46 on 52.8x normal volume
- Closed at $5.46, +34.81% vs the prior close of $4.05. Day range $3.91–$7.25, opened at $4.05.
- Volume was 3.34M shares, 52.8x its 50-day average of 63.29K — unusually heavy trading.
- Price is -8.7% vs its 50-day average ($5.98) and -61.7% vs its 200-day average ($14.26).
- 52-week range $3.00–$57.00; today's close sits at 5% of that range, 90.4% below the 52-week high.
Oct 13, 2026 — NXGL jumps 6.3% to $4.05
- Closed at $4.05, +6.30% vs the prior close of $3.81. Day range $3.68–$4.07, opened at $3.88.
- Volume was 74.30K shares, 1.2x its 50-day average of 61.82K.
- Price is -32.9% vs its 50-day average ($6.04) and -71.8% vs its 200-day average ($14.39).
- 52-week range $3.00–$57.00; today's close sits at 2% of that range, 92.9% below the 52-week high.
Oct 12, 2026 — NXGL slides 4.8% to $3.81 on 3.4x normal volume
- Closed at $3.81, -4.75% vs the prior close of $4.00. Day range $3.25–$4.43, opened at $3.96.
- Volume was 195.90K shares, 3.4x its 50-day average of 57.96K — unusually heavy trading.
- Price is -37.8% vs its 50-day average ($6.13) and -73.8% vs its 200-day average ($14.52).
- 52-week range $3.00–$57.00; today's close sits at 1% of that range, 93.3% below the 52-week high.
Oct 9, 2026 — NXGL jumps 33.3% to $4.00 on 11.1x normal volume
- Closed at $4.00, +33.33% vs the prior close of $3.00. Day range $3.02–$4.40, opened at $3.12.
- Volume was 524.77K shares, 11.1x its 50-day average of 47.48K — unusually heavy trading.
- Price is -35.7% vs its 50-day average ($6.22) and -72.7% vs its 200-day average ($14.66).
- 52-week range $3.00–$57.80; today's close sits at 2% of that range, 93.1% below the 52-week high.
Oct 8, 2026 — NXGL slides 15.3% to $3.00, a 52-week low
- Closed at $3.00, -15.25% vs the prior close of $3.54. Day range $3.00–$3.60, opened at $3.00.
- Volume was 67.25K shares, 1.5x its 50-day average of 46.15K.
- Price is -52.5% vs its 50-day average ($6.32) and -79.7% vs its 200-day average ($14.80).
- 52-week range $3.00–$57.80; today's close sits at 0% of that range, 94.8% below the 52-week high.
Oct 7, 2026 — NXGL rises 2.3% to $3.54
- Closed at $3.54, +2.31% vs the prior close of $3.46. Day range $3.24–$3.80, opened at $3.40.
- Volume was 31.88K shares, 0.7x its 50-day average of 45.53K.
- Price is -45.0% vs its 50-day average ($6.43) and -76.3% vs its 200-day average ($14.94).
- 52-week range $3.12–$57.80; today's close sits at 1% of that range, 93.9% below the 52-week high.
- SEC filings that day: 8-K.
Oct 6, 2026 — NXGL rises 1.8% to $3.46
- Closed at $3.46, +1.76% vs the prior close of $3.40. Day range $3.30–$3.48, opened at $3.40.
- Volume was 16.02K shares, 0.4x its 50-day average of 45.25K — lighter than usual.
- Price is -47.1% vs its 50-day average ($6.54) and -77.1% vs its 200-day average ($15.09).
- 52-week range $3.12–$57.80; today's close sits at 1% of that range, 94.0% below the 52-week high.
Oct 5, 2026 — NXGL dips 2.3% to $3.40, a 52-week low
- Closed at $3.40, -2.30% vs the prior close of $3.48. Day range $3.28–$3.46, opened at $3.40.
- Volume was 14.49K shares, 0.3x its 50-day average of 44.97K — lighter than usual.
- Price is -48.8% vs its 50-day average ($6.64) and -77.7% vs its 200-day average ($15.26).
- 52-week range $3.12–$57.80; today's close sits at 1% of that range, 94.1% below the 52-week high.
Oct 2, 2026 — NXGL dips 2.8% to $3.48
- Closed at $3.48, -2.79% vs the prior close of $3.58. Day range $3.26–$3.48, opened at $3.48.
- Volume was 11.11K shares, 0.2x its 50-day average of 44.77K — lighter than usual.
- Price is -48.5% vs its 50-day average ($6.75) and -77.4% vs its 200-day average ($15.41).
- 52-week range $3.12–$57.80; today's close sits at 1% of that range, 94.0% below the 52-week high.
NXGL latest news & SEC filings
Every SEC filing by or about NXGL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Sep 30, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 24, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 20, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 17, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $3.69M (prior year $2.88M) (+27.8% vs Jun 30, 2025)
- Net income: -$3.63M (prior year -$665.00K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.40 (prior year -$0.09) (loss widened vs Jun 30, 2025)
Aug 17, 2026 · Form NT 10-Q — Notice of late quarterly report
Notice of late quarterly report
Aug 14, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade NXGL
- Last results release: Aug 17, 2026 (8-K Item 2.02). Previous ones: Nov 12, 2025, Aug 12, 2025, May 13, 2025. Based on that rhythm, the next report is likely around Nov 16, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 8.39% (largest 34.8%). That is a volatile stock.
- Liquidity: about 239.61K shares (≈$1.34M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $5.59 vs a range of $3.00–$57.00 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Oct 12, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Adam R. Levy sold 5,000 shares on Jun 23, 2026.
- Latest filings: 8-K Oct 7, 2026; 8-K Sep 24, 2026; 8-K Sep 23, 2026.
- Share count: 9.75M shares outstanding (Aug 14, 2026), +20.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
NXGL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 5.10 | 5.87 | 5.10 | 5.59 | 53.62K |
| Oct 15, 2026 | 4.91 | 5.53 | 4.06 | 5.18 | 164.60K |
| Oct 14, 2026 | 4.05 | 7.25 | 3.91 | 5.46 | 3.34M |
| Oct 13, 2026 | 3.88 | 4.07 | 3.68 | 4.05 | 74.30K |
| Oct 12, 2026 | 3.96 | 4.43 | 3.25 | 3.81 | 195.90K |
| Oct 9, 2026 | 3.12 | 4.40 | 3.02 | 4.00 | 524.77K |
| Oct 8, 2026 | 3.00 | 3.60 | 3.00 | 3.00 | 67.25K |
| Oct 7, 2026 | 3.40 | 3.80 | 3.24 | 3.54 | 31.88K |
| Oct 6, 2026 | 3.40 | 3.48 | 3.30 | 3.46 | 16.02K |
| Oct 5, 2026 | 3.40 | 3.46 | 3.28 | 3.40 | 14.49K |
| Oct 2, 2026 | 3.48 | 3.48 | 3.26 | 3.48 | 11.11K |
| Oct 1, 2026 | 3.54 | 3.58 | 3.28 | 3.58 | 15.54K |
| Sep 30, 2026 | 3.46 | 3.68 | 3.32 | 3.46 | 16.48K |
| Sep 29, 2026 | 3.62 | 3.62 | 3.16 | 3.52 | 14.57K |
| Sep 28, 2026 | 3.58 | 3.78 | 3.48 | 3.56 | 38.34K |
| Sep 25, 2026 | 4.78 | 4.78 | 3.12 | 3.48 | 183.57K |
| Sep 24, 2026 | 5.40 | 5.60 | 5.00 | 5.24 | 16.70K |
| Sep 23, 2026 | 5.20 | 5.40 | 5.04 | 5.36 | 5.50K |
| Sep 22, 2026 | 5.28 | 5.52 | 5.22 | 5.50 | 1.27K |
| Sep 21, 2026 | 5.42 | 5.42 | 5.06 | 5.30 | 3.81K |
About Nexgel
Nexgel (NXGL) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in LANGHORNE, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1468929.
NXGL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kevin Mcclain Harris | Director | May 18, 2026 |
| Scott Robert Henry | Director | May 18, 2026 |
| Brian Joseph Kieser | Director | May 18, 2026 |
| Adam R. Levy | Chief Executive Officer | Jul 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ian Howard Blackman | Chief Financial Officer | May 7, 2026 |
| Adam R. Levy | Chief Executive Officer | Jul 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 23, 2026 | Adam R. Levy | Sale | 5,000 | $0.59 |
| Jun 23, 2026 | Adam R. Levy | Sale | 5,000 | $0.59 |
| Jun 23, 2026 | Adam R. Levy | Sale | 5,000 | $0.59 |
| Jun 23, 2026 | Adam R. Levy | Sale | 5,000 | $0.59 |
| Jun 18, 2026 | Adam R. Levy | Sale | 6,000 | $0.59 |
| Jun 18, 2026 | Adam R. Levy | Sale | 6,000 | $0.59 |
| Jun 18, 2026 | Adam R. Levy | Sale | 6,000 | $0.59 |
| Jun 18, 2026 | Adam R. Levy | Sale | 6,000 | $0.59 |
| Jun 11, 2026 | Adam R. Levy | Sale | 3,000 | $0.61 |
| Jun 11, 2026 | Adam R. Levy | Sale | 3,000 | $0.61 |
| Jun 11, 2026 | Adam R. Levy | Sale | 3,000 | $0.61 |
| Jun 11, 2026 | Adam R. Levy | Sale | 3,000 | $0.61 |
| Jun 8, 2026 | Adam R. Levy | Sale | 3,000 | $0.55 |
| Jun 8, 2026 | Adam R. Levy | Sale | 3,000 | $0.55 |
| Jun 8, 2026 | Adam R. Levy | Sale | 3,000 | $0.55 |
NXGL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $11.42M | $-3.00M | -0.38 | $-1.31M |
| Dec 31, 2024 | $8.69M | $-3.28M | -0.50 | $-3.87M |
| Dec 31, 2023 | $4.09M | $-3.16M | -0.56 | $-3.24M |
| Dec 31, 2022 | $2.05M | $-4.75M | -0.85 | $-2.99M |
| Dec 31, 2021 | — | $-4.31M | -1.45 | $-2.75M |
Latest balance sheet: total assets $26.45M, total liabilities $20.98M, cash $938.00K (as of Jun 30, 2026).
NXGL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 17, 2026 | 8-K Item 2.02 (results) | $7.52 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $40.40 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $54.20 |
| May 13, 2025 | 8-K Item 2.02 (results) | $55.20 |
| Mar 24, 2025 | 8-K Item 2.02 (results) | $61.80 |
| Jan 22, 2025 | 8-K Item 2.02 (results) | $65.60 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $63.60 |
| Oct 10, 2024 | 8-K Item 2.02 (results) | — |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| Jul 8, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NXGL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.